Fortress Biotech Inc

NASDAQ:FBIO  
2.05
-0.05 (-2.38%)
Mergers / Acquisitions

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products And Molecule Stabilizing Technology Franchise From Vyne Therapeutics

Published: 01/13/2022 12:19 GMT
Fortress Biotech Inc (FBIO) - Journey Medical Corporation Acquires Two FDA-approved Topical Minocycline Products and Molecule Stabilizing Technology Franchise From Vyne Therapeutics.
Journey Medical Corp - East West Bank Credit Agreement Expanded to $30.0 Million.
Journey Medical Corp - to Acquire Molecule Stabilizing Technology Franchise for an Upfront Payment of $20.0 Million.
Journey Medical Corp - Transaction Closed Simultaneously With Signing.